Risk of developing diabetic nephropathy is not associated with synergism between the angiotensin II (type 1) receptor C1166 allele and poor glycaemic control

Nephrology Dialysis Transplantation

Volumn 14, Issue 4, 1999, Pages 891-894

  Savage, David A ^a,b   Feeney, Susan A ^a   Fogarty, Damian G ^a   Maxwell, A Peter ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

Angiotensin II (type 1) receptor gene; Diabetic nephropathy; DNA polymorphism; Glycaemic control; Insulin dependent (type 1) diabetes mellitus; Renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ALLELE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE; RISK FACTOR;

EID: 0032891635     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/14.4.891     Document Type: Article

References (17)

1. Mathiesen ER, Hommel E, Giese J, Parving HH. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. Br Med J 1991; 303: 81-87
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496-501
3. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-1165
4. Borch-Johnsen K, Norgaard K, Hommel E et al. Is diabetic nephropathy an inherited complication? Kidney Int 1992; 41: 719-722
5. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996; 39: 940-945
6. Viberti GC, Keen H, Wiseman MJ. Raised arterial pressure in parents of proteinuric insulin dependent diabetics. Br Med J 1987; 295: 515-517
7. Krolewski AS, Canessa M, Warram JH et al. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-145
8. Barzilay J, Warram JH, Bak M, Laffel LM, Canessa M, Krolewski AS. Predisposition to hypertension: risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41: 723-730
9. Bonnardeaux A, Davies E, Jeunemaitre X et al. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994; 24; 63-69
10. Doria A, Onuma T, Warram JH, Krolewski AS. Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM. Diabetologia 1997; 40: 1293-1299
11. Fogarty DG, Harron JC, Hughes AE, Nevin NC, Doherty CC, Maxwell AP. A molecular variant of angiotensinogen is associated with diabetic nephropathy in IDDM. Diabetes 1996; 45: 1204-1208
12. Doria A, Ji L, Warram JH, Krolewski AS. Dde I polymorphism in the AGTR1 gene. Hum Mol Genet 1994; 3: 1444
13. Davies E, Bonnardeaux A, Lathrop GM, Corvol P, Clauser E, Soubrier F. Angiotensin II (type 1) receptor locus: CA repeat polymorphism and genetic mapping. Hum Mol Genet 1994; 3: 838
14. Doria A, Warram JH, Rich SS, Krolewski AS. Angiotensin I-converting enzyme (ACE): estimation of DNA haplotypes in unrelated individuals using denaturing gradient gel blots. Hum Genet 1994; 94: 117-123
15. Tarnow L, Cambien F, Rossing P et al. Angiotensin II type 1 receptor gene polymorphism and diabetic microangiography. Nephrol Dial Transplant 1996; 11: 1019-1023
16. Chowdhury TA, Dyer PH, Kumar S et al. Lack of association of the angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin-dependent diabetes mellitus. Diabetes Med 1997; 14: 837-840
17. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib pair analysis. Diabetes 1998; 47: 1164-1169